Cullinan Oncology, Inc.Cullinan Oncology, Inc.Cullinan Oncology, Inc.

Cullinan Oncology, Inc.

No trades
See on Supercharts
Market capitalization
‪777.77 M‬USD
−3.70USD
‪−153.16 M‬USD
‪26.36 M‬
Beta (1Y)
1.69

About Cullinan Oncology, Inc.

CEO
Nadim Ahmed
Headquarters
Cambridge
Employees (FY)
85
Founded
2016
ISIN
US2300311063
FIGI
BBG00HW2DGQ4
Cullinan Oncology, Inc. is a biopharmaceutical company engaged in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where CGEM is featured.

Frequently Asked Questions

The current price of CGEM is 15.66 USD — it has decreased by 13.29% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cullinan Oncology, Inc. stocks are traded under the ticker CGEM.
Cullinan Oncology, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
CGEM stock is 20.13% volatile and has beta coefficient of 1.69. Check out the list of the most volatile stocks — is Cullinan Oncology, Inc. there?
One year price forecast for Cullinan Oncology, Inc. has a max estimate of 36.00 USD and a min estimate of 19.00 USD.
CGEM earnings for the last quarter are −0.91 USD per share, whereas the estimation was −0.92 USD resulting in a 1.22% surprise. The estimated earnings for the next quarter are −0.96 USD per share. See more details about Cullinan Oncology, Inc. earnings.
Cullinan Oncology, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach ‪275.00 M‬ USD.
Yes, you can track Cullinan Oncology, Inc. financials in yearly and quarterly reports right on TradingView.
CGEM stock has fallen by 9.48% compared to the previous week, the month change is a 2.22% rise, over the last year Cullinan Oncology, Inc. has showed a 51.45% increase.
CGEM net income for the last quarter is ‪−23.80 M‬ USD, while the quarter before that showed ‪−39.18 M‬ USD of net income which accounts for 39.25% change. Track more Cullinan Oncology, Inc. financial stats to get the full picture.
Today Cullinan Oncology, Inc. has the market capitalization of ‪777.77 M‬, it has increased by 0.06% over the last week.
No, CGEM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CGEM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cullinan Oncology, Inc. stock right from TradingView charts — choose your broker and connect to your account.
CGEM reached its all-time high on Mar 10, 2021 with the price of 59.85 USD, and its all-time low was 7.30 USD and was reached on May 11, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 85.00 employees. See our rating of the largest employees — is Cullinan Oncology, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cullinan Oncology, Inc. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cullinan Oncology, Inc. stock shows the buy signal. See more of Cullinan Oncology, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Cullinan Oncology, Inc. future price: according to them, CGEM price has a max estimate of 36.00 USD and a min estimate of 19.00 USD. Read a more detailed Cullinan Oncology, Inc. forecast: see what analysts think of Cullinan Oncology, Inc. and suggest that you do with its stocks.